SES GmbH Analysesysteme
Friedhofstraße 7-9
55234 Bechenheim
Germany
Tel.: +49 (0) 6736 1301
Fax: +49 (0) 6736 1305
e-Mail: support@ses-dls.de
Friedhofstraße 7-9 - 55234 Bechenheim - Germany - e-Mail:support@ses-dls.de
NCE DP Dissolution and Permeation Testing Apparatus
Description
Real-time concentration monitoring is possible through the advanced technology
platform called NCE DP Dissolution and Permeation Testing. The system performs
dissolution and permeation analysis through its biological model coupled with its
optical fiber system which duplicates human body procedures to achieve precise
measurements. The system provides precise absorbance monitoring to enhance
biopharmaceutical classification. Data accuracy relies on Accurate Inside technology
and graphical results strengthen analysis effectiveness. The system lowers the
consumption of test samples which helps maximize experimental resource
utilization.
NCE DP6 In-situ Fiber Optic spectrometer
Description
The NCE DP6 in-situ fiber spectrometer combines a deuterium light source with a
photodiode array detector to capture key insights into drug dissolution in real time
with in-situ fiber technology
NCE SI Subcutaneous Injection Analysis System
Description
The NCE is Subcutaneous Injection Analysis serves as a testing device that imitates
the changes and stress factors that biopharmaceuticals along with peptides and
small molecule drugs face following subcutaneous administration. The device
assesses drug release patterns in vivo through a method that reproduces drug
dissolution together with permeation in extracellular matrices.
NCE P3 High-throughput Compound Screening Apparatus
Description
NCE P3 High-throughput Compound Screening presents itself as an automated
scientific instrument that performs compound screening work while conducting
related physical and chemical constant measurements. The device performs
accurate measurements of drug physical and chemical constants for pre-drug
prescriptions through titration by determining drug dissociation constants and oil-
water partition coefficients to support innovative drug development screening.